guest ::
| Home > Publications Database > Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. > print |
| Home > Publications Database > Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. > print |
| 001 | 138181 | ||
| 005 | 20240321220404.0 | ||
| 024 | 7 | _ | |a 10.1007/s00401-015-1483-3 |2 doi |
| 024 | 7 | _ | |a pmid:26439832 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC4612332 |2 pmc |
| 024 | 7 | _ | |a 0001-6322 |2 ISSN |
| 024 | 7 | _ | |a 1432-0533 |2 ISSN |
| 024 | 7 | _ | |a altmetric:4594501 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-04503 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wagner, Jens |0 P:(DE-2719)2662292 |b 0 |e First author |
| 245 | _ | _ | |a Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. |
| 260 | _ | _ | |a Heidelberg |c 2015 |b Springer |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2015-10-06 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2015-11-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1680084978_6872 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Pathological tau aggregation leads to filamentous tau inclusions and characterizes neurodegenerative tauopathies such as Alzheimer's disease and frontotemporal dementia and parkinsonism linked to chromosome 17. Tau aggregation coincides with clinical symptoms and is thought to mediate neurodegeneration. Transgenic mice overexpressing mutant human P301S tau exhibit many neuropathological features of human tauopathies including behavioral deficits and increased mortality. Here, we show that the di-phenyl-pyrazole anle138b binds to aggregated tau and inhibits tau aggregation in vitro and in vivo. Furthermore, anle138b treatment effectively ameliorates disease symptoms, increases survival time and improves cognition of tau transgenic PS19 mice. In addition, we found decreased synapse and neuron loss accompanied by a decreased gliosis in the hippocampus. Our results suggest that reducing tau aggregates with anle138b may represent an effective and promising approach for the treatment of human tauopathies. |
| 536 | _ | _ | |a 341 - Molecular Signaling (POF3-341) |0 G:(DE-HGF)POF3-341 |c POF3-341 |f POF III |x 0 |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole |2 NLM Chemicals |
| 650 | _ | 7 | |a Benzodioxoles |2 NLM Chemicals |
| 650 | _ | 7 | |a MAPT protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a Mapt protein, mouse |2 NLM Chemicals |
| 650 | _ | 7 | |a Neuroprotective Agents |2 NLM Chemicals |
| 650 | _ | 7 | |a Protein Aggregates |2 NLM Chemicals |
| 650 | _ | 7 | |a Pyrazoles |2 NLM Chemicals |
| 650 | _ | 7 | |a tau Proteins |2 NLM Chemicals |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Benzodioxoles: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Cell Death: drug effects |2 MeSH |
| 650 | _ | 2 | |a Cell Death: physiology |2 MeSH |
| 650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
| 650 | _ | 2 | |a Disease Progression |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Gliosis: drug therapy |2 MeSH |
| 650 | _ | 2 | |a Gliosis: pathology |2 MeSH |
| 650 | _ | 2 | |a Gliosis: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: drug effects |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: pathology |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Mice, Transgenic |2 MeSH |
| 650 | _ | 2 | |a Motor Activity: drug effects |2 MeSH |
| 650 | _ | 2 | |a Motor Activity: physiology |2 MeSH |
| 650 | _ | 2 | |a Neurons: drug effects |2 MeSH |
| 650 | _ | 2 | |a Neurons: pathology |2 MeSH |
| 650 | _ | 2 | |a Neurons: physiology |2 MeSH |
| 650 | _ | 2 | |a Neuroprotective Agents: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Protein Aggregates: drug effects |2 MeSH |
| 650 | _ | 2 | |a Pyrazoles: pharmacology |2 MeSH |
| 650 | _ | 2 | |a Random Allocation |2 MeSH |
| 650 | _ | 2 | |a Recognition, Psychology: drug effects |2 MeSH |
| 650 | _ | 2 | |a Recognition, Psychology: physiology |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: drug therapy |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: pathology |2 MeSH |
| 650 | _ | 2 | |a tau Proteins: genetics |2 MeSH |
| 650 | _ | 2 | |a tau Proteins: metabolism |2 MeSH |
| 700 | 1 | _ | |a Krauß, Sybille |0 P:(DE-2719)2421562 |b 1 |
| 700 | 1 | _ | |a Shi, Song |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Ryazanov, Sergey |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Steffen, Julia |0 P:(DE-2719)2810279 |b 4 |
| 700 | 1 | _ | |a Miklitz, Carolin |0 P:(DE-2719)2810438 |b 5 |
| 700 | 1 | _ | |a Leonov, Andrei |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Kleinknecht, Alexander |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Göricke, Bettina |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Weishaupt, Jochen H |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Weckbecker, Daniel |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Reiner, Anne M |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Zinth, Wolfgang |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Levin, Johannes |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Ehninger, Dan |0 P:(DE-2719)2289209 |b 14 |
| 700 | 1 | _ | |a Remy, Stefan |0 P:(DE-2719)2810375 |b 15 |
| 700 | 1 | _ | |a Kretzschmar, Hans A |0 P:(DE-HGF)0 |b 16 |
| 700 | 1 | _ | |a Griesinger, Christian |0 P:(DE-HGF)0 |b 17 |
| 700 | 1 | _ | |a Giese, Armin |0 P:(DE-HGF)0 |b 18 |
| 700 | 1 | _ | |a Fuhrmann, Martin |0 P:(DE-2719)2679991 |b 19 |e Last author |
| 773 | 1 | 8 | |a 10.1007/s00401-015-1483-3 |b : Springer Science and Business Media LLC, 2015-10-06 |n 5 |p 619-631 |3 journal-article |2 Crossref |t Acta Neuropathologica |v 130 |y 2015 |x 0001-6322 |
| 773 | _ | _ | |a 10.1007/s00401-015-1483-3 |g Vol. 130, no. 5, p. 619 - 631 |0 PERI:(DE-600)1458410-4 |n 5 |q 130:5<619 - 631 |p 619-631 |t Acta neuropathologica |v 130 |y 2015 |x 0001-6322 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/138181/files/DZNE-2020-04503.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/138181/files/DZNE-2020-04503.pdf?subformat=pdfa |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612332 |
| 909 | C | O | |o oai:pub.dzne.de:138181 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2662292 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2421562 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2810279 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2810438 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2289209 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)2810375 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 19 |6 P:(DE-2719)2679991 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-341 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Molecular Signaling |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 1 |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b ACTA NEUROPATHOL : 2017 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ACTA NEUROPATHOL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 920 | 1 | _ | |0 I:(DE-2719)1011004 |k AG Fuhrmann |l Neuroimmunology and Imaging |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1011006 |k AG Krauß |l Regulatory RNA-protein interaction in neurodegenerative diseases |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1013006 |k AG Remy |l Neuronal Networks |x 2 |
| 920 | 1 | _ | |0 I:(DE-2719)1013005 |k AG Ehninger |l Translational Biogerontology |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1011004 |
| 980 | _ | _ | |a I:(DE-2719)1011006 |
| 980 | _ | _ | |a I:(DE-2719)1013006 |
| 980 | _ | _ | |a I:(DE-2719)1013005 |
| 980 | 1 | _ | |a FullTexts |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/anie.201208290 |2 Crossref |o 10.1002/anie.201208290 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/WNL.42.3.631 |2 Crossref |o 10.1212/WNL.42.3.631 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.bbrc.2011.06.135 |2 Crossref |o 10.1016/j.bbrc.2011.06.135 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1021/jm100138f |2 Crossref |o 10.1021/jm100138f |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S0002-9440(10)63421-9 |2 Crossref |o 10.1016/S0002-9440(10)63421-9 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.0587-07.2007 |2 Crossref |o 10.1523/JNEUROSCI.0587-07.2007 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nprot.2006.205 |2 Crossref |o 10.1038/nprot.2006.205 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.97.10.5468 |2 Crossref |o 10.1073/pnas.97.10.5468 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.4363-10.2010 |2 Crossref |o 10.1523/JNEUROSCI.4363-10.2010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/BF00308809 |2 Crossref |o 10.1007/BF00308809 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.3059-10.2010 |2 Crossref |o 10.1523/JNEUROSCI.3059-10.2010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1097/00005072-199906000-00011 |2 Crossref |o 10.1097/00005072-199906000-00011 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/anie.200704051 |2 Crossref |o 10.1002/anie.200704051 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JAD-132477 |2 Crossref |o 10.3233/JAD-132477 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.M111.229633 |2 Crossref |o 10.1074/jbc.M111.229633 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.4161/auto.19048 |2 Crossref |o 10.4161/auto.19048 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nrneurol.2013.223 |2 Crossref |o 10.1038/nrneurol.2013.223 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1212/01.WNL.0000063311.58879.01 |2 Crossref |o 10.1212/01.WNL.0000063311.58879.01 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.bbrc.2004.06.075 |2 Crossref |o 10.1016/j.bbrc.2004.06.075 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1177/0269881109359098 |2 Crossref |o 10.1177/0269881109359098 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/0304-3940(95)11484-E |2 Crossref |o 10.1016/0304-3940(95)11484-E |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1038/nprot.2006.180 |2 Crossref |o 10.1038/nprot.2006.180 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/ana.410410106 |2 Crossref |o 10.1002/ana.410410106 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1371/journal.pone.0052389 |2 Crossref |o 10.1371/journal.pone.0052389 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.cell.2012.02.040 |2 Crossref |o 10.1016/j.cell.2012.02.040 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/jnen/60.6.647 |2 Crossref |o 10.1093/jnen/60.6.647 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E |2 Crossref |o 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-004-0917-0 |2 Crossref |o 10.1007/s00401-004-0917-0 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.M507753200 |2 Crossref |o 10.1074/jbc.M507753200 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1146/annurev.neuro.24.1.1121 |2 Crossref |o 10.1146/annurev.neuro.24.1.1121 |
| 999 | C | 5 | |y 2011 |2 Crossref |o VM Lee 2011 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00415-003-1074-4 |2 Crossref |o 10.1007/s00415-003-1074-4 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.3233/JAD-2001-3117 |2 Crossref |o 10.3233/JAD-2001-3117 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1021/bi0600749 |2 Crossref |o 10.1021/bi0600749 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1750-1326-7-35 |2 Crossref |o 10.1186/1750-1326-7-35 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1186/1750-1326-5-45 |2 Crossref |o 10.1186/1750-1326-5-45 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/med.20177 |2 Crossref |o 10.1002/med.20177 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.M410984200 |2 Crossref |o 10.1074/jbc.M410984200 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1021/bi700878g |2 Crossref |o 10.1021/bi700878g |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.1065-09.2009 |2 Crossref |o 10.1523/JNEUROSCI.1065-09.2009 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1126/science.1113694 |2 Crossref |o 10.1126/science.1113694 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1093/brain/aws143 |2 Crossref |o 10.1093/brain/aws143 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K |2 Crossref |o 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/S1474-4422(13)70090-5 |2 Crossref |o 10.1016/S1474-4422(13)70090-5 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1074/jbc.M409876200 |2 Crossref |o 10.1074/jbc.M409876200 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-002-0520-1 |2 Crossref |o 10.1007/s00401-002-0520-1 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1007/s00401-013-1114-9 |2 Crossref |o 10.1007/s00401-013-1114-9 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1073/pnas.93.20.11213 |2 Crossref |o 10.1073/pnas.93.20.11213 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuron.2013.07.046 |2 Crossref |o 10.1016/j.neuron.2013.07.046 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1016/j.neuron.2007.01.010 |2 Crossref |o 10.1016/j.neuron.2007.01.010 |
| 999 | C | 5 | |9 -- missing cx lookup -- |a 10.1523/JNEUROSCI.4922-11.2012 |2 Crossref |o 10.1523/JNEUROSCI.4922-11.2012 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|